Company intelligence / Profile preview

Dash Pharmaceuticals LLC

Saddle River/PARSIPPANY [HQ], New Jersey, USAbiospace.com ↗
Ownership
Private
Employees
~4
Development stage
Commercial
01

Overview

Dash Pharmaceuticals was a New Jersey-based pharmaceutical sales and distribution company specializing in marketing generic pharmaceutical products in the United States. In January 2022 it was acquired by Natco Pharma Inc. USA for $18 million to serve as the front-end commercial arm for Natco’s US operations. As of January 2024 all Dash-branded products transitioned to the "Natco Pharma USA" label with no change to NDC numbers or product availability. The acquisition provided Natco with direct access to US customers and expanded its presence in the world’s largest pharma market.

Therapeutic areas
OncologyImmunologyNeurologyNephrologyInfectious Diseases
Modalities
Small molecules (generic drugs)Complex formulations
Industry
Biotech
02

Drug pipeline

3 assets

lenalidomide

Commercial
Indications
Cancer

2 more assets in the full pipeline.

Request access →
03

Partnerships

Co-development/licensing partnerships with leading U.S. generic companies via parent organization since at least 2007.

Beyond the preview

Go deeper on Dash Pharmaceuticals LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dash Pharmaceuticals LLC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call